BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was PLN 50.38 million compared to PLN 41.15 million a year ago. Net income was PLN 6.08 million compared to PLN 4.25 million a year ago.

Basic earnings per share from continuing operations was PLN 0.09 compared to PLN 0.07 a year ago. Diluted earnings per share from continuing operations was PLN 0.09 compared to PLN 0.07 a year ago.